Prostate Cancer
PSMAcTION: A phase II/III, open-label, international, multicenter, randomized study of AAA817 versus standard of care in the treatment of adult participants with PSMA-positive metastatic castration-resistant prostate cancer who progressed on or after [177Lu]Lu-PSMA targeted therapyProtocol No.: CAAA817A12201
- Details
ClinicalTrials.gov ID:
NCT06780670
Diagnosis Type:
NA
USOR Number:
- Address
,
P: